PHI with Calcium dichromate allergy
How does this condition affect your private health insurance?
Kalziumdichromatallergie, or Calcium Dichromate Allergy, is a common form of allergic contact dermatitis, a type IV hypersensitivity reaction. It occurs when an individual's skin comes into contact with calcium dichromate or other chromate compounds, often found in industrial settings like cement, leather, and metal-plating. Symptoms typically include intensely itchy, red, swollen, and sometimes blistering skin lesions appearing hours to days after exposure. Chronic exposure can lead to persistent dermatitis with skin thickening and scaling. Diagnosis is confirmed through patch testing. Management primarily involves strict avoidance of the allergen, coupled with symptomatic treatment using topical corticosteroids to alleviate inflammation and itching. This allergy can significantly impact quality of life.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to a few weeks, resolving with allergen avoidance and treatment
Duration of Illness (Lifetime)
Lifelong sensitization; symptoms recur with re-exposure
Cost of Treatment (Initial)
Moderate, involving doctor visits, patch testing, and topical medications (e.g., $100-$1000)
Cost of Treatment (Lifetime)
Variable, potentially high if recurring exposure requires ongoing treatment, or if occupational changes are necessary
Mortality Rate
Extremely low (virtually none directly from the allergy)
Risk of Secondary Damages
Moderate to high (e.g., secondary skin infections from scratching, chronic eczema, lichenification, significant impact on quality of life, potential for occupational disability)
Probability of Full Recovery
High for symptomatic resolution with strict allergen avoidance; however, sensitization is lifelong
Underlying Disease Risk
Low (not directly associated with other specific underlying diseases, though general atopic predisposition may exist)